ESSA Pharma (EPIX) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free EPIX Stock Alerts $6.25 -0.49 (-7.27%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ESSA Pharma Short Interest DataCurrent Short Volume769,300 sharesPrevious Short Volume802,800 sharesChange Vs. Previous Month-4.17%Dollar Volume Sold Short$5.62 millionShort Interest Ratio / Days to Cover5.8Last Record DateApril 15, 2024Outstanding Shares44,240,000 sharesPercentage of Shares Shorted1.74%Today's Trading Volume31,946 sharesAverage Trading Volume126,134 sharesToday's Volume Vs. Average25% Short Selling ESSA Pharma ? Sign up to receive the latest short interest report for ESSA Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEPIX Short Interest Over TimeEPIX Days to Cover Over TimeEPIX Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide ESSA Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024769,300 shares $5.62 million -4.2%N/A5.8 $7.30 3/31/2024802,800 shares $6.82 million -13.6%N/A5.2 $8.49 3/15/2024928,600 shares $8.36 million -5.2%4.6%6.1 $9.00 2/29/2024979,400 shares $9.30 million -13.3%4.8%6.3 $9.50 2/15/20241,130,000 shares $11.25 million -19.9%5.6%7.4 $9.96 1/31/20241,410,000 shares $11.69 million +5.2%7.1%9.5 $8.29 Get the Latest News and Ratings for EPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ESSA Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,340,000 shares $13.32 million No Change6.7%7.8 $9.94 12/31/20231,340,000 shares $8.84 million -1.5%6.7%6.9 $6.60 12/15/20231,360,000 shares $8.47 million -2.9%6.8%7.1 $6.23 11/30/20231,400,000 shares $7.45 million +1.5%7.0%7.7 $5.32 11/15/20231,380,000 shares $7.25 million +1.5%6.9%7.8 $5.25 10/31/20231,360,000 shares $6.32 million +3,959.7%6.8%8.3 $4.65 10/15/202333,500 shares $91,790.00 -32.5%0.2%0.3 $2.74 9/30/202349,600 shares $153,264.00 +73.4%0.3%1.7 $3.09 9/15/202328,600 shares $75,790.00 -4.7%0.1%0.9 $2.65 8/31/202330,000 shares $90,000.00 -42.2%0.2%0.9 $3.00 8/15/202351,900 shares $159,852.00 +8.1%0.3%1.4 $3.08 7/31/202348,000 shares $144,960.00 -29.1%0.2%1.3 $3.02 7/15/202367,700 shares $192,945.00 -27.9%0.4%1.7 $2.85 6/30/202393,900 shares $253,530.00 -21.6%0.5%1.9 $2.70 6/15/2023119,700 shares $389,025.00 -18.5%0.6%2.2 $3.25 5/31/2023146,900 shares $440,700.00 -14.1%0.8%2.2 $3.00 5/15/2023171,000 shares $499,320.00 -11.2%0.9%2.3 $2.92 4/30/2023192,600 shares $529,650.00 -33.8%1.0%1.7 $2.75 4/15/2023290,900 shares $805,793.00 +2.8%1.6%1.9 $2.77 3/31/2023282,900 shares $840,213.00 -1.4%1.5%1.4 $2.97 3/15/2023287,000 shares $826,560.00 +21.2%1.5%1.3 $2.88 2/28/2023236,800 shares $796,832.00 +17.0%1.3%1 $3.37 2/15/2023202,400 shares $718,520.00 -26.6%1.1%0.7 $3.55 1/31/2023275,800 shares $783,272.00 -20.6%1.5%0.9 $2.84 1/15/2023347,500 shares $966,050.00 -1.6%1.9%0.1 $2.78 12/30/2022353,000 shares $889,560.00 -18.1%1.9%0.1 $2.52 12/15/2022431,100 shares $1.22 million -20.9%2.3%0.1 $2.84 11/30/2022545,000 shares $2.01 million -11.9%2.9%0.2 $3.69 11/15/2022618,300 shares $2.46 million -69.4%3.3%0.2 $3.98 10/31/20222,020,000 shares $7.27 million +472.9%11.6%0.6 $3.60 10/15/2022352,600 shares $691,096.00 -5.7%2.0%2.1 $1.96 9/30/2022373,800 shares $680,316.00 +5.4%2.2%1.5 $1.82 9/15/2022354,500 shares $794,080.00 -5.5%2.0%0.9 $2.24 8/31/2022375,000 shares $967,500.00 +28.1%2.2%1 $2.58The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him EPIX Short Interest - Frequently Asked Questions What is ESSA Pharma's current short interest? Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 769,300 shares of EPIX short. Learn More on ESSA Pharma's current short interest. What is a good short interest ratio for ESSA Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EPIX shares currently have a short interest ratio of 6.0. Learn More on ESSA Pharma's short interest ratio. Is ESSA Pharma's short interest increasing or decreasing? ESSA Pharma saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 769,300 shares, a decline of 4.2% from the previous total of 802,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ESSA Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ESSA Pharma: Nanobiotix S.A. (0.11%), Aquestive Therapeutics, Inc. (4.40%), Procaps Group S.A. (0.03%), Akebia Therapeutics, Inc. (6.54%), Verastem, Inc. (3.94%), UroGen Pharma Ltd. (17.91%), XOMA Co. (2.42%), Inozyme Pharma, Inc. (7.66%), Vanda Pharmaceuticals Inc. (3.80%), Neoleukin Therapeutics, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ESSA Pharma stock? Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. EPIX shares are trading down $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ESSA Pharma? A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further. How often is ESSA Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NBTX Short Interest Data AQST Short Interest Data PROC Short Interest Data AKBA Short Interest Data VSTM Short Interest Data URGN Short Interest Data XOMA Short Interest Data INZY Short Interest Data VNDA Short Interest Data NLTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EPIX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research